FDA Inspection 1215711 — Holly C. Wall, M.D.
The FDA completed an inspection of Holly C. Wall, M.D. on Aug 3, 2023 in Shreveport, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 3, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Shreveport, LA (United States)
Additional details
Clinical Investigator (CI)